There are reasons to suggest that immune checkpoint inhibitors may be successful against central nervous system tumors, including glioblastoma.
Dale Chenoweth
Advertisement
Articles by Dale Chenoweth
Advertisement
Latest Updated Articles
Immune Checkpoint Inhibitors Hold Promise In GlioblastomaPublished: November 20th 2015 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
4
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
5